Add Yahoo as a preferred source to see more of our stories on Google. Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or ...

As part of a years-long effort by PrEP4ALL and other HIV groups to get Gilead Sciences, a pharmaceutical company, to lower ...

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, research, and programs will jeopardize that progress. In the United States, ...

Deploying lenacapavir will require rethinking who delivers HIV prevention, how it is financed, and what policy infrastructure must be built, and rebuilt, to match the science.

Nonprofits received up to $400,000 each to expand prevention models led by community health workers. The two-year grants are part of a larger initiative that includes more than 30 organizations across ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...

Unlike daily PrEP, the injection is administered once every six months, offering continuous protection over that period.

HIV PREVENTION. BETHEL. >> YEAH, SO. >> THIS ISN’T JUST ABOUT MEDICINE. THIS IS ABOUT CONFIDENCE CONTROL AND PROTECTION. I TALKED TO A LOCAL ADVOCATE WHO’S LIVING WITH HIV AND PROUDLY OWNING HER STORY ...

Reductions in US global health aid are disrupting HIV prevention and treatment programs in South Africa, potentially ...

Indiana will end a statewide HIV outreach and testing program this summer after health officials say a drop in federal ...